M3 Inc
TSE:2413
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 152
2 507
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
M3 Inc
M3 Inc
Cash & Cash Equivalents
M3 Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
M3 Inc
TSE:2413
|
Cash & Cash Equivalents
¥57m
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
-43%
|
|
|
EM Systems Co Ltd
TSE:4820
|
Cash & Cash Equivalents
¥9.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
S
|
Software Service Inc
TSE:3733
|
Cash & Cash Equivalents
¥14B
|
CAGR 3-Years
24%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
|
|
Medley Inc
TSE:4480
|
Cash & Cash Equivalents
¥15.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
JMDC Inc
TSE:4483
|
Cash & Cash Equivalents
¥27.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
e
|
eWeLL Co Ltd
TSE:5038
|
Cash & Cash Equivalents
¥1.4B
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M3 Inc
Glance View
M3 Inc., a pioneering force in healthcare information services, has carved a niche for itself by leveraging deep insights and technological innovation to enhance medical communication and research. Founded in Japan in 2000, the company developed a robust platform that connects healthcare professionals with pharmaceutical companies, facilitating the efficient flow of information and ensuring that practitioners have access to the latest medical advancements. This focus on bridging the gap between industry players not only streamlines the dissemination of critical knowledge but also fosters a collaborative ecosystem that drives continuous medical education and patient care improvements. With a blend of data analytics and a vast network of professionals, M3 Inc. has successfully positioned itself as a go-to partner for both healthcare providers and drug manufacturers. As the company expanded its operations internationally, it adopted a strategic vision that includes significant investments in technology and data management. M3 Inc. caters to a diverse range of needs within the healthcare sector, from market research to digital marketing solutions. The firm’s innovative approach has led to impressive growth in revenue and a solid market presence across Asia and beyond. For investors, M3 Inc. represents a compelling opportunity, as its business model is designed to capitalize on the ongoing digital transformation of the healthcare industry. With a commitment to delivering substantial value and a clear growth trajectory, M3 Inc. stands poised to play an integral role in shaping the future of healthcare communication and innovation.
See Also
What is M3 Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
57m
JPY
Based on the financial report for Sep 30, 2024, M3 Inc's Cash & Cash Equivalents amounts to 57m JPY.
What is M3 Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-43%
Over the last year, the Cash & Cash Equivalents growth was -100%. The average annual Cash & Cash Equivalents growth rates for M3 Inc have been -91% over the past three years , -74% over the past five years , and -43% over the past ten years .
You don't have any saved screeners yet
